UPDATE: Canaccord Genuity Downgrades Momenta Pharmaceuticals (MNTA) to Hold; Negative Copaxone Ruling
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
(Updated - June 25, 2012 8:23 AM EDT)
Canaccord Genuity downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Buy to Hold with a price target of $12.00 (from $17.00).
Analyst, Ritu Baral, said, "M-enox revenues are now a modest royalty stream. Friday’s negative ruling on Copaxone delays potential launch of M356 (generic Copaxone). While MNTA's Baxter-partnered biosimilars program and branded drugs have significant long-term potential, lack of near-term catalysts likely limits 12-month upside."
For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $17.01 yesterday.
Canaccord Genuity downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Buy to Hold with a price target of $12.00 (from $17.00).
Analyst, Ritu Baral, said, "M-enox revenues are now a modest royalty stream. Friday’s negative ruling on Copaxone delays potential launch of M356 (generic Copaxone). While MNTA's Baxter-partnered biosimilars program and branded drugs have significant long-term potential, lack of near-term catalysts likely limits 12-month upside."
For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $17.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Libra Energy Materials options two Quebec lithium projects near Cisco
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
